Publication | Open Access

In vitro and in vivo activities of a novel β-lactamase inhibitor combination imipenem/XNW4107 against recent clinical Gram-negative bacilli from China

Antimicrobial ChemotherapyBacterial PathogensDrug ResistanceVivo ActivitiesAntibacterial MechanismsAntimicrobial ResistanceHealth SciencesAntimicrobial Drug DiscoveryAntibacterial AgentAntimicrobial PharmacokineticsAntimicrobial CompoundPharmacologyClinical MicrobiologyAntimicrobial SusceptibilityAntibioticsMicrobiologyAntimicrobial PharmacodynamicsMedicineDrug Discovery